Clopidogrel Versus Newer P2Y12 Antagonists for Percutaneous Coronary Intervention in Patients with Out-of-Hospital Cardiac Arrest Managed with Therapeutic Hypothermia: A Meta-Analysis

被引：5
作者：
Elbadawi A. [1 ]
Elgendy I.Y. [2 ]
Mohamed A.H. [3 ]
Barssoum K. [3 ]
Alotaki E. [3 ]
Ogunbayo G.O. [4 ]
Ziada K.M. [4 ]
机构：
[1] Department of Cardiovascular Medicine, University of Texas Medical Branch, Galveston, TX
[2] Division of Cardiovascular Medicine, University of Florida, Gainesville, FL
[3] Internal Medicine Department, Rochester General Hospital, Rochester, NY
[4] Department of Cardiovascular Medicine, University of Kentucky, Lexington, KY
来源：
Cardiology and Therapy | 2018年 / 7卷 / 2期
关键词：
Anti-platelets; Percutaneous coronary intervention; Stent thrombosis; Therapeutic hypothermia;
D O I：
10.1007/s40119-018-0118-x
中图分类号：
学科分类号：
摘要：
Introduction: The impact of therapeutic hypothermia (TH) on outcomes of percutaneous coronary intervention (PCI) and the optimal antiplatelet treatment remains debatable. Methods: Electronic databases were searched for randomized trials and observational studies to evaluate the available clinical evidence comparing the use of clopidogrel versus newer P2Y12 antagonists in cases of TH after PCI. The primary outcome was in-hospital definite stent thrombosis while the secondary outcomes were in-hospital mortality and major bleeding. Fixed-effects risk ratios (RRs) were estimated using Mantel–Haenszel method. Results: The final analysis included five studies with a total of 290 patients. There was no difference in the incidence of stent thrombosis (RR 0.92; 95% CI 0.35–2.38), in-hospital mortality (RR 1.38; 95% CI 0.72–2.65), and major bleeding (RR 0.89; 95% CI 0.33–2.40) between patients receiving clopidogrel versus those receiving newer agents. Conclusions: This meta-analysis showed no difference between clopidogrel and newer antiplatelet agents in the incidence of stent thrombosis or in-hospital mortality for PCI in cases of TH. Further randomized studies are needed to explore the optimal dual antiplatelet treatment in TH. © 2018, The Author(s).
引用
收藏
页码：185 / 189
页数：4
相关论文
共 9 条
  • [1] Moudgil R., Al-Turbak H., Osborne C., Hibbert B., So D.Y., Le May M.R., Investigators C., Superiority of ticagrelor over clopidogrel in patients after cardiac arrest undergoing therapeutic hypothermia, Can J Cardiol, 30, pp. 1396-1399, (2014)
  • [2] Steblovnik K., Blinc A., Mijovski M.B., Fister M., Mikuz U., Noc M., Ticagrelor versus clopidogrel in comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention and hypothermia, Circulation, 134, pp. 2128-2130, (2016)
  • [3] Gouffran G., Rosencher J., Bougouin W., Jakamy R., Joffre J., Lamhaut L., Dumas F., Cariou A., Varenne O., Stent thrombosis after primary percutaneous coronary intervention in comatose survivors of out-of-hospital cardiac arrest: are the new P2Y 12 inhibitors really more effective than clopidogrel?, Resuscitation, 98, pp. 73-78, (2016)
  • [4] Jimenez-Britez G., Freixa X., Flores-Umanzor E., San Antonio R., Caixal G., Garcia J., Hernandez-Enriquez M., Andrea R., Regueiro A., Masotti M., Out-of-hospital cardiac arrest and stent thrombosis: ticagrelor versus clopidogrel in patients with primary percutaneous coronary intervention under mild therapeutic hypothermia, Resuscitation, 114, pp. 141-145, (2017)
  • [5] Hogberg C., Erlinge D., Braun O.O., Mild hypothermia does not attenuate platelet aggregation and may even increase ADP-stimulated platelet aggregation after clopidogrel treatment, Thromb J, 7, (2009)
  • [6] Bednar F., Kroupa J., Ondrakova M., Osmancik P., Kopa M., Motovska Z., Antiplatelet efficacy of P2Y12 inhibitors (prasugrel, ticagrelor, clopidogrel) in patients treated with mild therapeutic hypothermia after cardiac arrest due to acute myocardial infarction, J Thromb Thrombolysis, 41, pp. 549-555, (2016)
  • [7] Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.A., Gabriel Steg P., Morel M.A., Mauri L., Vranckx P., Clinical end points in coronary stent trials: a case for standardized definitions, Circulation, 115, pp. 2344-2351, (2007)
  • [8] Wells G., Shea B., O'Connell D., Petersen J., Welch V., Losos M., Tugwell P., The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analyses, (2012)
  • [9] Lagerqvist B., Carlsson J., Frobert O., Lindback J., Schersten F., Stenestrand U., James S.K., Stent thrombosis in Sweden, Circ Cardiovasc Interv, 2, pp. 401-408, (2009)
1